Ryu Kimura
Papers
1
Total Citations
8
H-Index
1
About
Dr. Ryu Kimura is a leading health services researcher specializing in the comparative effectiveness and economic evaluation of prostate cancer treatments, with a particular focus on active surveillance. His major contribution lies in quantifying the real-world medical costs of different management strategies for low-risk prostate cancer, providing critical evidence for clinical decision-making and healthcare policy. In his landmark 2022 study using data from the PRIAS-JAPAN cohort, Dr. Kimura demonstrated that active surveillance is significantly less expensive than robot-assisted prostatectomy, brachytherapy, intensity-modulated radiation therapy, and hormone therapy—findings that have been cited 8 times and are shaping cost-conscious treatment guidelines. His work bridges the gap between clinical outcomes and economic sustainability, helping patients and physicians weigh the financial burden of early cancer care. Dr. Kimura’s research is particularly impactful in Japan’s aging society, where optimizing healthcare resource allocation is paramount. By rigorously analyzing protocol biopsy costs and long-term surveillance expenses, he has established a framework for value-based oncology that is increasingly influential among urologists and health economists worldwide.
Research Focus
Key Achievements
Top Papers
- 1